Doctors stage non-small cell lung cancer (NSCLC) according to how far it has progressed. Stages range from occult (or hidden) cancer to stage 4 cancer, in which multiple organs may be affected.

A recent analysis shows that additional invasive staging modalities lead to relevant changes in target volume in some patients with NSCLC but do not impact survival.

The prognosis of non-small cell lung cancer varies depending on the specific subtype and the stage of cancer at diagnosis. Early-stage NSCLC—when the cancer is confined to one or two lungs ...

Stage 4 non-small cell lung cancer (NSCLC) is the most advanced form of the condition and can be challenging to treat. Treatments include chemotherapy, surgery, immunotherapy, and radiotherapy.

How Do You Treat SCLC and NSCLC? There are different options for treating lung cancer. The treatment you get depends on the type and stage of your lung cancer, and other factors like your age and ...

In early NSCLC, researchers found a stepwise decline in 5-year survival as income quartile declined, implicating income as a ...

SUZHOU, China I March 23, 2025 I CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer ...

While surgery has been a primary treatment option for some early-stage NSCLC patients, recurrence rates of 30% to 55% highlight the need for additional perioperative interventions. “Given the ...

Patients diagnosed with lung cancer have a very poor survival rate, in the United Kingdom, of those presenting with advanced disease (late stage ... defined: non-small-cell lung cancer (NSCLC ...

FDG PET-derived imaging biomarkers of airway inflammation and their clinical associations in patients with non-small cell ...